Ann Arbor, MI Should I use estrogen replacement therapy (ERT) after a...
Health Information Should I use estrogen replacement therapy (ERT) after a hysterectomy and oophorectomy?
Should I use estrogen replacement therapy (ERT) after a hysterectomy and oophorectomy?
Introduction
This information will help you understand your choices,
whether you share in the decision-making process or rely on your doctor's
recommendation.
Key points in making your decision
As researchers
learn more about the effects of
estrogen replacement therapy (ERT) on the body, women
are asking more questions about whether ERT is right for them. If you are
considering whether to start or stop taking ERT, consider the following when
making your decision:
If you have early
menopause after a
hysterectomy and
oophorectomy (or a while after a hysterectomy or
oophorectomy), your doctor will probably recommend that you take ERT. ERT
replaces some or all of the
estrogen that your ovaries would be making at this
time in your life. Without the estrogen, you may have
menopausal symptoms. You would also be at risk for
having weaker bones later in life. For most women in their 20s, 30s, or 40s,
ERT benefits outweigh the slight risk of blood clots that comes with taking
estrogen.
If you are near the age of natural menopause (around age 50),
talk to your doctor about the risks and benefits of starting ERT after
hysterectomy and oophorectomy. In large groups of women in their 60s and older,
slightly more women on ERT develop breast cancer or ovarian cancer or have a
stroke than do women not taking ERT.1, 2
If you are near the age of natural menopause (around age 50),
you may not need to take ERT after hysterectomy and oophorectomy. Talk to your
doctor about either stopping ERT and using other treatments that don't use
hormones, or continuing ERT beyond menopausal age (at as low a dose as
possible).
If you smoke, try to quit smoking before taking ERT. At
any age, your risk of blood clots (deep vein thrombosis) is slightly increased when you take estrogen. It's best not
to combine this risk with smoking, which increases your risk for cardiovascular
disease.
ERT does not lower risks of heart disease and dementia, as was
thought in the past.
A
hysterectomy is the surgical removal of the
uterus. Hysterectomy is sometimes used for
gynecological problems that haven't improved with other treatment. These
problems include abnormally heavy menstrual bleeding,
uterine fibroids,
endometriosis,
chronic pelvic pain, and
uterine prolapse. Less commonly, hysterectomy is a
lifesaving treatment for uncontrollable bleeding during childbirth or for
cancer.
What is an oophorectomy, and why is it done?
An
oophorectomy is the surgical removal of the
ovaries. About half of American women who have a
hysterectomy also have their ovaries removed (bilateral oophorectomy).3
When taking
hormone therapy after an oophorectomy only (the uterus
is not removed), it's important to take estrogen plus
progestin (hormone replacement therapy, or HRT). The progestin protects the
uterus from the increased risk of estrogen-related
endometrial cancer.
Sometimes
oophorectomy is intended to treat a condition that is triggered or made worse
by the ovaries' hormone changes, such as severe, untreatable
premenstrual syndrome (PMS), endometriosis, or
premenopausal breast cancer. In other cases, ovary removal is done to reduce
the possibility of
ovarian cancer (which is rare but difficult to
detect). Oophorectomy may also be performed to remove a growth from one ovary
or both ovaries.
What is estrogen replacement therapy (ERT)?
Estrogen replacement therapy (ERT) is the use of man-made (synthetic)
estrogen to replace the natural estrogen normally produced by your ovaries. ERT
is available in pill form (oral form) or as a skin patch, vaginal ring, or skin
cream or gel (transdermal form).
Why is ERT prescribed?
Until menopause (usually
around age 50), the ovaries make most of your body's estrogen. When the ovaries
are removed (oophorectomy), estrogen levels suddenly drop. This change causes
early menopause and increased
osteoporosis risk (your body's estrogen helps keep
bones strong).
Historically, women in their 20s, 30s, and early
40s-before menopausal age-have been prescribed ERT after hysterectomy with
oophorectomy or ERT with progestin after oophorectomy alone. (Without
progestin, ERT can lead to uterine cancer.)
Although oophorectomy
causes a sudden drop in estrogen, hysterectomy alone can lead to a more
gradual, yet early decline of estrogen (premature ovarian failure) in some women. In either case, keeping estrogen levels up
protects against early bone density loss and helps prevent menopausal symptoms.
ERT may not be necessary for most women after the age of natural
menopause (around age 50). Until further research clarifies this question,
there are no current ERT treatment guidelines for older women to follow. Women
taking ERT can consider:
Continuing ERT beyond menopausal age to treat
menopausal symptoms (using as low a dose as possible).
Stopping ERT
and using other symptom treatments that don't use hormones.
For more information, see the topic Menopause and
Perimenopause.
What are the benefits of ERT after hysterectomy with oophorectomy?
Estrogen replacement therapy reverses the effect of
low estrogen and therefore:
Reduces
osteoporosis risk. ERT slows bone loss and promotes
some increase in bone density.4
Reduces
the frequency and severity of
hot flashes.4
Prevents or reverses vaginal dryness and
irritation caused by low estrogen.
Slows the decline in skin
collagen levels. Collagen is responsible for the
stretch in skin and muscle.
Reduces the risk of dental problems,
such as tooth loss and gum disease.
May help prevent
depression and sleep problems related to hormone
changes.5
What are the risks of ERT?
Estrogen replacement
therapy increases your risk of:6
Breast cancer. The Million Women Study has shown that, in women
using ERT for 10 years, the number of breast cancers is slightly higher than
normal. It appears that ERT causes breast cancer in 5 out of 1,000
women.2 Although the
Women's Health Initiative (WHI) trial found no
increase in breast cancer over 7 years of ERT use, experts continue to take the
breast cancer risk seriously.1
Gallstones. Women who use estrogen replacement therapy
are more likely to have gallstones that cause symptoms than women who do not
use ERT. (High estrogen levels are linked to gallbladder disease.)
Ovarian cancer (which is rare). In women using ERT
over 5 years, the number of ovarian cancers is slightly higher. Using ERT
causes ovarian cancer in about 0.4 out of 1,000 women. (This is the same as 1
out of 2,500 women.) This risk only applies to women who have their ovaries and
are taking estrogen.
Have active liver disease or long-term impaired liver
function. (Estrogen applied to the skin via cream, gel, or patch does not
stress the liver to the same degree as estrogen pills).
Have a
personal history of breast cancer, ovarian cancer, blood clots, or
stroke.
If you are a smoker, try to quit smoking.
Talk to your doctor about your risks versus benefits if you have a family history of breast cancer, ovarian cancer,
stroke, or blood clots.
After having a hysterectomy and oophorectomy (or a
hysterectomy only, followed by early menopause), your choices are to:
Take estrogen replacement therapy
(ERT).
Use other treatment measures for menopausal symptoms and
osteoporosis prevention.
The decision about whether to use or continue using
estrogen replacement therapy (ERT) takes into account your personal feelings
and the medical facts.
Deciding about estrogen replacement therapy (ERT)
Reasons to use or continue
using estrogen replacement therapy (ERT)
Reasons to not use or not
continue using estrogen replacement therapy
You have had a hysterectomy and
oophorectomy (or a hysterectomy only, followed by early menopause) in your 20s,
30s, or 40s AND:
You need a treatment for severe
menopausal symptoms and have considered or tried other treatment
options.
You need a treatment for preventing early bone loss and
osteoporosis.
You have a family history
of stroke, breast cancer, or ovarian cancer, but you and your doctor consider
your risk to be small and will watch closely for such health
problems.
You are older than 55, have talked with your doctor about
continuing to take ERT, have considered other treatment options, and have
decided that ERT benefits outweigh the possible risks to you.
Are there other reasons you might want to use ERT?
You have had a hysterectomy but have not
had your ovaries removed, and you are having no symptoms of early
menopause.
You have a personal history of stroke, breast cancer, or
ovarian cancer.
You are a smoker.
You have reached the
average age of menopause (age 50), when a woman's estrogen levels naturally
decline, and you would like to taper off of ERT.
Are there other reasons you might not want to use
ERT?
Use this worksheet to help you make your decision.
After completing it, you should have a better idea of how you feel about taking
estrogen replacement therapy. Discuss the worksheet with your doctor.
Circle the answer that best applies to you.
I had an oophorectomy and hysterectomy in
my 20s, 30s, or 40s.
Yes
No
NA*
I have had a hysterectomy in my 20s, 30s,
or 40s, followed by early menopause.
Yes
No
NA
I am younger than menopausal age
(50).
Yes
No
NA
I am older than menopausal age.
Yes
No
NA
I am a smoker.
Yes
No
NA
I need a treatment for severe menopausal
symptoms and have considered or tried other treatment options.
Yes
No
Unsure
I need a treatment for preventing early
bone loss and osteoporosis.
Yes
No
Unsure
I have a personal or family history of
stroke, breast cancer, or ovarian cancer.
Yes
No
Unsure
I take ERT and am beyond the age of natural
menopause.
Yes
No
NA
I have risk factors for osteoporosis and am
concerned that low estrogen in my body will increase my risk.
Yes
No
Unsure
I have osteoporosis and have tried or
seriously considered non-ERT bone-protecting treatments.
Yes
No
NA
I have considered other treatment options,
such as vaginal lubricants for dryness and irritation; antidepressants for hot
flashes and mood-related problems; and vitamin D, calcium, and bisphosphonate
medicine for preventing osteoporosis.
Yes
No
NA
*NA=Not applicable
Use
the following space to list any other important concerns you have about this
decision.
What is your overall impression?
Your answers in
the above worksheet are meant to give you a general idea of where you stand on
this decision. You may have one overriding reason to use or not use estrogen
replacement therapy.
Check the box below that represents your
overall impression about your decision.
Women's Health Initiative Steering Committee (2004).
Effects of conjugated equine estrogen in postmenopausal women with
hysterectomy. JAMA, 291(14): 1701-1712.
Million Women Study Collaborators (2003). Breast
cancer and hormone-replacement therapy in the Million Women Study.
Lancet, 362(9382): 419-427.
American College of Obstetricians and Gynecologists
(1999, reaffirmed 2005). Prophylactic oophorectomy. ACOG Practice Bulletin No.
7. Obstetrics and Gynecology, 94(3): 1-7.
Speroff L, Fritz MA (2005). Menopause and the
perimenopausal transition. In Clinical Gynecologic Endocrinology and Infertility, 7th ed., pp. 621-688. Philadelphia:
Lippincott Williams and Wilkins.
Rapkin AJ, et al. (2002). The clinical nature and
formal diagnosis of premenstrual, postpartum, and perimenopausal affective
disorders. Current Psychiatry Reports, 4(6):
419-428.
Rossouw JE, et al. (2002). Risks and benefits of
estrogen plus progestin in healthy postmenopausal women. Principal results from
the Women's Health Initiative randomized controlled trial. JAMA, 288(3): 321-333.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
Women's Health Initiative Steering Committee (2004).
Effects of conjugated equine estrogen in postmenopausal women with
hysterectomy. JAMA, 291(14): 1701-1712.
Million Women Study Collaborators (2003). Breast
cancer and hormone-replacement therapy in the Million Women Study.
Lancet, 362(9382): 419-427.
American College of Obstetricians and Gynecologists
(1999, reaffirmed 2005). Prophylactic oophorectomy. ACOG Practice Bulletin No.
7. Obstetrics and Gynecology, 94(3): 1-7.
Speroff L, Fritz MA (2005). Menopause and the
perimenopausal transition. In Clinical Gynecologic Endocrinology and Infertility, 7th ed., pp. 621-688. Philadelphia:
Lippincott Williams and Wilkins.
Rapkin AJ, et al. (2002). The clinical nature and
formal diagnosis of premenstrual, postpartum, and perimenopausal affective
disorders. Current Psychiatry Reports, 4(6):
419-428.
Rossouw JE, et al. (2002). Risks and benefits of
estrogen plus progestin in healthy postmenopausal women. Principal results from
the Women's Health Initiative randomized controlled trial. JAMA, 288(3): 321-333.